Ondansetron
Term · Oncology and biomedicine · MLC-T-ONC-015669
A carbazole derivative with antiemetic activity. As a selective serotonin receptor antagonist, ondansetron competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
| Identifier | MLC-T-ONC-015669 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015669",
"term": "Ondansetron",
"field": "Oncology and biomedicine",
"definition": "A carbazole derivative with antiemetic activity. As a selective serotonin receptor antagonist, ondansetron competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ondansetron/"
}
Record 12,236 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.